Across TCGA pan-cancer cohorts, SCGB1D4 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SCGB1D4 data layer compared with 11 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SCGB1D4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SCGB1D4 expression acts as an unfavorable survival marker.

LIHC are the cancer types where SCGB1D4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.031	0.777	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SCGB1D4 tumor-vs-normal RNA expression · all SCGB1D4 data types